Search research articles
Contact Us
Filters
Showing results (81-90 of 115) with videos related to
Page
of 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2013
Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients
L Boussemart, E Routier, C Mateus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2017
Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer
R Condorelli, L Spring, J O'Shaughnessy, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
October 6, 2006
Randomized trial of exercise in sedentary middle aged women: effects on quality of life
Deborah J Bowen, Megan D Fesinmeyer, Yutaka Yasui, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 1999
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy
G Cantin, B L'Espérance, L Yelle, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 21, 2014
Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?
M Macerelli, C Caramella, L Faivre, et al.
Endocrine-Related Cancer
|
December 25, 2010
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan, et al.
Leukemia
|
December 13, 2005
Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis
C James, F Delhommeau, C Marzac, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 2001
Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay
J L Mergny, L Lacroix, M P Teulade-Fichou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?
S Postel-Vinay, Y Boursin, C Massard, et al.
British Journal of Cancer
|
August 11, 2011
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
F Farace, C Massard, N Vimond, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 115) with videos related to
Sort By:
Page
of 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2013
Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients
L Boussemart, E Routier, C Mateus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2017
Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer
R Condorelli, L Spring, J O'Shaughnessy, et al.
The International Journal of Behavioral Nutrition and Physical Activity
|
October 6, 2006
Randomized trial of exercise in sedentary middle aged women: effects on quality of life
Deborah J Bowen, Megan D Fesinmeyer, Yutaka Yasui, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 1999
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy
G Cantin, B L'Espérance, L Yelle, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 21, 2014
Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?
M Macerelli, C Caramella, L Faivre, et al.
Endocrine-Related Cancer
|
December 25, 2010
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan, et al.
Leukemia
|
December 13, 2005
Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis
C James, F Delhommeau, C Marzac, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 2001
Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay
J L Mergny, L Lacroix, M P Teulade-Fichou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?
S Postel-Vinay, Y Boursin, C Massard, et al.
British Journal of Cancer
|
August 11, 2011
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
F Farace, C Massard, N Vimond, et al.
Page
of 12